2024 Digital Therapeutics Conference Seeks Global Partners to Advance Digital Health Ecosystem
VCBeat
Internet Medical Health Media
Since its inception, VCBeat has remained focused on the transformation of the healthcare industry driven by the dual engines of “new technologies” and “new healthcare reforms,” particularly the new business opportunities and industrial ecosystems emerging from this transformation, the innovative enterprises rising to prominence, and the repositioning of industry professionals in this era of change.
As a pioneer in reporting on and researching digital therapeutics in China since 2016, and having released12copyDigital Therapeutics-Related Reports, Exceeding300 articlesVCBeat and VCBeat Institute, weAdhering to long-termism, we grow alongside the industry and are committed to promoting the development of the industrial ecosystem.
VCBeat VB100 is preparing for the 2024 Digital Therapeutics Conference, which will focus more onAligned with the Current Market Environment and Industry TrendsofInnovation Conference on Digital Therapeutics and Digital Health, scheduled to be held in Haikou, Hainan in early September, with investment and cooperation initiatives officially launched!
Review of Previous Conferences
1. Annual Gala of Digital Therapeutics,Policy interpretation, R&D releases, industry trends, and industrial dynamics, etc.Focusing on Cutting-Edge Hot Topics,Track development trends in key areas,Building a Future Industry Outlook Station.
2. Convening global experts, corporate perspectives, and experience sharing; a deep collaboration and empowerment matrix involving government agencies from multiple countries and regions, health commissions of various provinces and cities in China, and leading hospital departments,Contributing Chinese Wisdom and Strength to Building a Global Digital Therapeutics Community.
Past Attendees (Partial List)
3.An Integrated Hub for the Full Industry Chain of the Digital Health Ecosystem,Comprehensive Industry Networking. The attendees are primarily elites from the healthcare industry, including entrepreneurs, investors, listed companies, research institutions, government bodies, and third-party supply chain partners, with management and decision-makers accounting for 16% of the participants.
Analysis of Past Attendee Demographics
The 2024 Digital Therapeutics Conference is China's firstCentered on Digital Therapeutics and the Full-Chain Ecosystem of Digital Healtha global conference focusing on the latest international trends in digital health, clinical department use cases, and integration and collaboration across the industrial chain ecosystem. By leveraging diverse formats—including selections of innovative international products and technologies, collection of clinical scenario needs, matchmaking for ecosystem cooperation, summits on cutting-edge themes, and roadshows for early-stage projects—it aims to build a comprehensive communication and matchmaking platform for the entire digital health industry chain.
Leveraging Hainan Province as the “Global Digital Therapeutics Innovation Island” and its strategic hub and showcase, the conference brings together the most active international and regional dignitaries in digital health, academicians and experts in the field of digital health, scholars from universities and research institutions in healthcare, Fortune 500 and publicly listed companies, innovative enterprises, partners across the medical industry chain, and renowned financial and investment institutions. The aim is to drive boundary-breaking integration, application, and innovation of digital therapeutics within the healthcare industry.
This year, the Innovation Conference on Digital Therapeutics and Digital Health will place greater emphasis on aligning with the current market environment and industry trends, starting fromDigital Healthcare Application Scenarios, Industry and Pan-Ecosystem Collaborative Partnerships, International EcosystemPrepare along three core directions
Application Scenarios in Digital Healthcare
Practical Implementation Across Disease-Specific Departments and Clinical Scenarios: Closed-Loop Practices Spanning Regulatory Authorities, In-Hospital and Out-of-Hospital Settings, and Business Models; Inviting Health Commissions and Hospitals from Hainan Province and Nationwide Benchmarks to Participate in Exchanges.
Industry and Pan-Ecosystem Collaboration Directions
Yucong Medicine: Initiating cross-sector collaboration between serious healthcare and health consumerism through diversified partnerships among pharmaceutical, medical device, and innovative enterprises.
International Ecosystem Direction
Anticipating international trends and policies from mainstream global embassies, consulates, and government associations to facilitate dialogues on market expansion for both outbound Chinese enterprises and foreign companies entering the Chinese market.
The Organizing Committee offers various partnership models, including “Strategic Partnership,” “Co-Hosting,” and “Ecosystem Collaboration.”Sincerely Inviting Ecosystem Partners from the Entire Digital Health Industry(including but not limited toVenture Capital Firms,Industry associations, universities and research institutes, scientific research institutions, industryMedia,Innovative Enterprises, etc.) provide relevant support, achieve resource sharing and integration through an innovative ecosystem co-creation model, and inject sustained innovative momentum into the conference ecosystem.
